eCential news and highlights

2019/06/27

Surgivisio launches pediatric app

Gières, France, June 27, 2019 - Surgivisio today announced the launch of its pediatric application for spine surgery. The French company, which markets the only unified surgical platform combining 2D fluoroscopy, 3D imaging and real-time navigation, now offers its customers a pediatric mode with an additional X-ray optimization for dose reduction.

"The development of a pediatric mode that would enable us to reduce the x-ray dose for intra-operative imaging of children was a priority for us," explained Stéphane Lavallée, Surgivisio’s president. "For some organs, young patients have higher sensitivity to ionizing radiation and cancer than adults, and a lower x-ray dose is often sufficient for imaging of smaller patients.”

Children will now be able to be operated on with the Surgivisio platform, previously available only for adult patients. "Surgery for major deformities of the child's spine, such as scoliosis, is a real therapeutic challenge, as the vertebrae are very deformed, which affects the usual anatomical landmarks,” explained Dr. Aurélien Courvoisier, pediatric orthopaedic surgeon at the Grenoble-Alpes university hospital. "The surgeon must be able to safely place implants in the vertebrae in such a way as to ensure a solid anchorage of the rods that will allow the overall deformation to be corrected. The Surgivisio system is a particularly fast and reliable surgical navigation system that helps surgeons secure implant placements. The Surgivisio system also makes it possible to optimize the minimally-invasive scoliosis correction procedures that we are developing in Grenoble. Less radiant, this system is in line with our efforts to reduce children's exposure to X-rays during the follow-up and treatment of scoliosis. »

Protected by over thirty patents, Surgivisio’s technology enabled the company to win phases 1, 2 and 3 of the World Innovation Challenge, and to benefit from an investment in 2018 of 10.7 million euros led by Bpifrance.